BCAXBicara Therapeutics Inc. Common Stock
23.90USD-7.58%Mkt Cap: 1.58B $P/E: —3d ago
Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors. Its lead program is ficerafusp alfa, a bifunctional antibody that combines a cl…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap1.58B $
Enterprise Value1.12B $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-137.95M $
Revenue/Share—
Last Price23.90 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees103
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-7.05
PEG—
EV/EBITDA-5.54
EV/Revenue—
P/S—
P/B3.43
EPS (TTM)-2.89
EPS (Forward)-3.46
52W Range
10.2966% of range30.99
52W High30.99 USD
52W Low10.29 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-34.36%
ROA-32.01%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-106.83M $
CapEx (TTM)280.00K $
FCF Margin—
FCF Yield-4.87%
Net Debt-496.10M $
Net Debt/EBITDA2.46
Balance Sheet
Debt/Equity0.00
Current Ratio11.59
Quick Ratio11.44
Book Value/Sh7.110 USD
Cash/Share7.515 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.6 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)33.50 USD
Upside (mean)+40.2%
Target Range20.00 USD – 45.00 USD
$20.00+40.2% to mean$45.00
# Analysts14
Ownership
Shares Out.66.17M
Float36.90M
Insiders10.07%
Institutions111.20%
Short Interest
Short Ratio15.3d
Short % Float20.40%
Short % Out.14.61%
Shares Short9.60M
Short (prev mo.)10.12M
Technical
SMA 5026.29 (-9.1%)
SMA 20020.51 (+16.5%)
Beta—
S&P 52W Chg18.16%
Avg Vol (30d)568.47K
Avg Vol (10d)727.80K
Technical Indicators
RSI (14)41.6
MACD-0.6039
MACD Signal-0.4003
MACD Hist.-0.2037
BB Upper28.62 USD
BB Middle25.76 USD
BB Lower22.91 USD
BB Width22.14%
ATR (14)1.553 USD
Vol Ratio (20d)0.73x